Publications by authors named "Deborah A Dillon"

34Publications

Histopathologic features of breast cancer in Li-Fraumeni syndrome.

Mod Pathol 2020 Jul 7. Epub 2020 Jul 7.

Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-020-0610-4DOI Listing
July 2020

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.

NPJ Breast Cancer 2020 12;6:17. Epub 2020 May 12.

21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-020-0156-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217863PMC
May 2020

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.

J Pathol 2020 04 9;250(5):667-684. Epub 2020 Apr 9.

Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.5406DOI Listing
April 2020

Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations.

Mod Pathol 2020 07 13;33(7):1287-1297. Epub 2020 Jan 13.

Division of Breast Surgery, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-020-0459-6DOI Listing
July 2020

Neutralization of BCL-2/X Enhances the Cytotoxicity of T-DM1 .

Mol Cancer Ther 2019 06 8;18(6):1115-1126. Epub 2019 Apr 8.

Department of Cell Biology and Ludwig Center at Harvard, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-18-0743DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758547PMC
June 2019

In Vitro Liquid Extraction Surface Analysis Mass Spectrometry (ivLESA-MS) for Direct Metabolic Analysis of Adherent Cells in Culture.

Anal Chem 2018 04 2;90(8):4987-4991. Epub 2018 Apr 2.

Department of Cancer Biology , Dana-Farber Cancer Institute, Harvard Medical School , Boston , Massachusetts 02115 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.analchem.8b00530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196362PMC
April 2018

Nipple-Invasive Primary Carcinomas: Clinical, Imaging, and Pathologic Features of Breast Carcinomas Originating in the Nipple.

Arch Pathol Lab Med 2018 May 12;142(5):598-605. Epub 2018 Feb 12.

From the Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, Kentucky (Dr Sanders); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Brock, Harrison, Dillon, and Lester); the Department of Pathology, Brigham and Women's Faulkner Hospital, Boston, Massachusetts (Drs Wieczorek and Hong); the Department of Pathology, Newton-Wellesley Hospital, Newton, Massachusetts (Dr Guidi); and Falmouth Hospital, Falmouth, Massachusetts (Dr Max).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0226-OADOI Listing
May 2018

An Update of Mucinous Lesions of the Breast.

Surg Pathol Clin 2018 Mar 6;11(1):61-90. Epub 2017 Dec 6.

Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Amory 3, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2017.09.002DOI Listing
March 2018

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2018 02 3;36(6):543-553. Epub 2018 Jan 3.

Daniel G. Stover, Ohio State University Comprehensive Cancer Center, Columbus, OH; Heather A. Parsons, Gavin Ha, William T. Barry, Hao Guo, Atish D. Choudhury, Melissa E. Hughes, Deborah A. Dillon, Ann H. Partridge, Nikhil Wagle, Ian E. Krop, Todd R. Golub, Eric P. Winer, Sara M. Tolaney, and Nancy U. Lin, Dana-Farber Cancer Institute; Gad Getz, Massachusetts General Hospital, Boston; Gavin Ha, Samuel S. Freeman, Atish D. Choudhury, Gregory Gydush, Sarah C. Reed, Justin Rhoades, Denisse Rotem, Nikhil Wagle, Gad Getz, Todd R. Golub, and Viktor A. Adalsteinsson, Broad Institute of Harvard and Massachusetts Institute of Technology; and J. Christopher Love, Massachusetts Institute of Technology, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.0033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815405PMC
February 2018

Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors.

Cancer Cell 2016 Mar;29(3):255-269

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794996PMC
March 2016

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System.

Arch Pathol Lab Med 2015 Sep 2;139(9):1087-93. Epub 2015 Feb 2.

From the Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia (Dr Brat); the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Dillon); the Department of Pathology, Indiana University Medical Center, Indianapolis (Dr Hattab); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr McLendon); Cancer Registry, Saint Agnes Hospital, Baltimore, Maryland (Ms Miller); and the Department of Oncology, Mayo Clinic, Rochester, Minnesota (Dr Buckner).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0588-CPDOI Listing
September 2015

ICAM-1 as a molecular target for triple negative breast cancer.

Proc Natl Acad Sci U S A 2014 Oct 29;111(41):14710-5. Epub 2014 Sep 29.

Department of Biomedical Engineering, The City College of New York, New York, NY 10031; Vascular Biology Program, Boston Children's Hospital, Boston, MA 02115; Department of Surgery, Harvard Medical School, Boston, MA 02115;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1408556111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205631PMC
October 2014

Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast.

Arch Pathol Lab Med 2014 May 15;138(5):595-601. Epub 2013 Nov 15.

From the Department of Pathology, St Jude Medical Center, Fullerton, California (Dr Fitzgibbons); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Dillon); the Department of Pathology, Kaiser Permanente-Los Angeles Medical Center, Los Angeles, California (Dr Alsabeh); the Department of Pathology, Jefferson Hospital, Jefferson Hills, Pennsylvania (Dr Berman); the Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor (Dr Hayes); the Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York (Dr Hicks); the Division of Surgical Oncology, Massachusetts General Hospital, Boston (Dr Hughes); and the Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada (Dr Nofech-Mozes).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2013-0566-CPDOI Listing
May 2014

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

Breast Cancer Res Treat 2013 May 12;139(1):193-8. Epub 2013 Apr 12.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2375-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280061PMC
May 2013

Trastuzumab for the treatment of salivary duct carcinoma.

Oncologist 2013 21;18(3):294-300. Epub 2013 Feb 21.

Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607526PMC
September 2013

IQGAP1 protein binds human epidermal growth factor receptor 2 (HER2) and modulates trastuzumab resistance.

J Biol Chem 2011 Aug 1;286(34):29734-47. Epub 2011 Jul 1.

Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M111.220939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191015PMC
August 2011

A comparison of estrogen receptor SP1 and 1D5 monoclonal antibodies in routine clinical use reveals similar staining results.

Am J Clin Pathol 2009 Sep;132(3):396-401

Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPSKFWOLPPMEU9DOI Listing
September 2009

Lesions of the Nipple.

Surg Pathol Clin 2009 Jun 2;2(2):391-412. Epub 2009 Jun 2.

Harvard Medical School, 25 Shattuck Street, Boston, MA 02114 USA; Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2009.02.010DOI Listing
June 2009

2D LC/MS analysis of membrane proteins from breast cancer cell lines MCF7 and BT474.

J Proteome Res 2004 Nov-Dec;3(6):1278-83

Department of Chemical Engineering, Yale University, New Haven, CT 06520-8286, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/pr049852eDOI Listing
April 2005

Molecular markers in the diagnosis and staging of breast cancer.

Authors:
Deborah A Dillon

Semin Radiat Oncol 2002 Oct;12(4):305-18

Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/srao.2002.35249DOI Listing
October 2002

p53 mutations as tumor markers in fine needle aspirates of palpable breast masses.

Acta Cytol 2002 Sep-Oct;46(5):841-7

Department of Pathology-LH219, Yale University School of Medicine, P.O. Box 208023, New Haven, Connecticut 06520-8023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000327057DOI Listing
October 2002